Antithrombotic Drugs - Global Market Outlook (2016-2022)

January 2017 | 184 pages | ID: A5DDE6B1834EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Antithrombotic Drugs market is accounted for $XX million in 2016 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2016 to 2022. Rising prevalence of chronic diseases associated with thrombotic disease require long-term administration of antithrombotic drugs, which is the key factor enhancing the demand for antithrombotic drugs market. Furthermore, growing geriatric population, increasing hereditary diseases, lack of physical activity, increasing awareness among patients about life-threatening diseases, changing lifestyles and increasing hypertension are the factors favouring market growth. However, off- patented drugs, postoperative bleeding and availability of generic antithrombotic drugs would restrict the antithrombotic drugs market growth. Furthermore, new product launches by key vendors, up-gradation in the antithrombotic drugs and recent R&D programs by major players to develop new drugs are the key opportunities for the market.

Asia Pacific is expected to grasp major revenue and volume share in antithrombotic drugs market and is expected to grow with a high CAGR during the forecast period. This growth is attributed to increasing patient population in China and India. North America and Europe regions have significant penetration of antithrombotic drugs due to continual R&D activities for new drug development and high prevalence rate of cardiac and cancer diseases.

Some of the key global players in antithrombotic drugs market are Bayer AG, Johnson & Johnson Services Inc., Sanofi, Boehringer Ingelheim GmbH, Pfizer Inc., Abbott laboratories, Dr. Reddy’s Laboratories, Pharmacia Inc., Eli Lilly and Company, The Medicines Company, Genentech Inc., Bristol-Myers Squibb., Watson laboratories inc, Zydus pharmaceuticals Inc. and Otsuka.

Drug Types Covered:

• Anticoagulant
• Thrombolytic drugs
• Antiplatelet

Drug Classes Covered:

• Edoxaban
• Fondaparinux
• Heparin
• Apixaban
• Debigatran
• Rivaroxaban

Indications Covered:

• Myocardial infarction (MI)
• Venous thromboembolism (VTE)
• Stroke
• Acute coronary syndrome (ACS)
• Peripheral arterial occlusion (PAO)
• Other Indications

Route of Administration Covered:

• Oral route
• Parenteral route

Applications Covered:

• Blood clot prevention
• Hyperlipidemia treatment
• Prophylactic treatment
• Thromboembolic disease treatment
• Other Applications

Distribution Channels Covered:

• Hospital Pharmacies
• Online Retailers
• General Pharmacies
• Drug Stores

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL ANTITHROMBOTIC DRUGS MARKET, BY DRUG TYPE

5.1 Introduction
5.2 Anticoagulant
5.3 Thrombolytic drugs
5.4 Antiplatelet

6 GLOBAL ANTITHROMBOTIC DRUGS MARKET, BY DRUG CLASS

6.1 Introduction
6.2 Edoxaban
6.3 Fondaparinux
6.4 Heparin
6.5 Apixaban
6.6 Debigatran
6.7 Rivaroxaban

7 GLOBAL ANTITHROMBOTIC DRUGS MARKET, BY INDICATION

7.1 Introduction
7.2 Myocardial infarction (MI)
7.3 Venous thromboembolism (VTE)
7.4 Stroke
7.5 Acute coronary syndrome (ACS)
7.6 Peripheral arterial occlusion (PAO)
7.7 Other Indications

8 GLOBAL ANTITHROMBOTIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION

8.1 Introduction
8.2 Oral route
8.3 Parenteral route

9 GLOBAL ANTITHROMBOTIC DRUGS MARKET, BY APPLICATION

9.1 Introduction
9.2 Blood clot prevention
9.3 Hyperlipidemia treatment
9.4 Prophylactic treatment
9.5 Thromboembolic disease treatment
9.6 Other Applications

10 GLOBAL ANTITHROMBOTIC DRUGS MARKET, BY DISTRIBUTION CHANNEL

10.1 Introduction
10.2 Hospital Pharmacies
10.3 Online Retailers
10.4 General Pharmacies
10.5 Drug Stores

11 GLOBAL ANTITHROMBOTIC DRUGS MARKET, BY GEOGRAPHY

11.1 North America
  11.1.1 US
  11.1.2 Canada
  11.1.3 Mexico
11.2 Europe
  11.2.1 Germany
  11.2.2 France
  11.2.3 Italy
  11.2.4 UK
  11.2.5 Spain
  11.2.6 Rest of Europe
11.3 Asia Pacific
  11.3.1 Japan
  11.3.2 China
  11.3.3 India
  11.3.4 Australia
  11.3.5 New Zealand
  11.3.6 Rest of Asia Pacific
11.4 Rest of the World
  11.4.1 Middle East
  11.4.2 Brazil
  11.4.3 Argentina
  11.4.4 South Africa
  11.4.5 Egypt

12 KEY DEVELOPMENTS

12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 COMPANY PROFILING

13.1 Bayer AG
13.2 Johnson & Johnson Services Inc.
13.3 Sanofi
13.4 Boehringer Ingelheim GmbH
13.5 Pfizer Inc.
13.6 Abbott laboratories
13.7 Dr. Reddy’s Laboratories
13.8 Pharmacia Inc.
13.9 Eli Lilly and Company
13.10 The Medicines Company
13.11 Genentech Inc.
13.12 Bristol-Myers Squibb.
13.13 Watson laboratories inc
13.14 Zydus pharmaceuticals Inc.
13.15 Otsuka

List Of Tables

LIST OF TABLES

Table 1 Global Antithrombotic Drugs Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Antithrombotic Drugs Market Outlook, By Drug Type (2014-2022) ($MN)
Table 3 Global Antithrombotic Drugs Market Outlook, By Anticoagulant (2014-2022) ($MN)
Table 4 Global Antithrombotic Drugs Market Outlook, By Thrombolytic drugs (2014-2022) ($MN)
Table 5 Global Antithrombotic Drugs Market Outlook, By Antiplatelet (2014-2022) ($MN)
Table 6 Global Antithrombotic Drugs Market Outlook, By Drug Class (2014-2022) ($MN)
Table 7 Global Antithrombotic Drugs Market Outlook, By Edoxaban (2014-2022) ($MN)
Table 8 Global Antithrombotic Drugs Market Outlook, By Fondaparinux (2014-2022) ($MN)
Table 9 Global Antithrombotic Drugs Market Outlook, By Heparin (2014-2022) ($MN)
Table 10 Global Antithrombotic Drugs Market Outlook, By Apixaban (2014-2022) ($MN)
Table 11 Global Antithrombotic Drugs Market Outlook, By Debigatran (2014-2022) ($MN)
Table 12 Global Antithrombotic Drugs Market Outlook, By Rivaroxaban (2014-2022) ($MN)
Table 13 Global Antithrombotic Drugs Market Outlook, By Indication (2014-2022) ($MN)
Table 14 Global Antithrombotic Drugs Market Outlook, By Myocardial infarction (MI) (2014-2022) ($MN)
Table 15 Global Antithrombotic Drugs Market Outlook, By Venous thromboembolism (VTE) (2014-2022) ($MN)
Table 16 Global Antithrombotic Drugs Market Outlook, By Stroke (2014-2022) ($MN)
Table 17 Global Antithrombotic Drugs Market Outlook, By Acute coronary syndrome (ACS) (2014-2022) ($MN)
Table 18 Global Antithrombotic Drugs Market Outlook, By Peripheral arterial occlusion (PAO) (2014-2022) ($MN)
Table 19 Global Antithrombotic Drugs Market Outlook, By Other Indications (2014-2022) ($MN)
Table 20 Global Antithrombotic Drugs Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 21 Global Antithrombotic Drugs Market Outlook, By Oral route (2014-2022) ($MN)
Table 22 Global Antithrombotic Drugs Market Outlook, By Parenteral route (2014-2022) ($MN)
Table 23 Global Antithrombotic Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 24 Global Antithrombotic Drugs Market Outlook, By Blood clot prevention (2014-2022) ($MN)
Table 25 Global Antithrombotic Drugs Market Outlook, By Hyperlipidemia treatment (2014-2022) ($MN)
Table 26 Global Antithrombotic Drugs Market Outlook, By Prophylactic treatment (2014-2022) ($MN)
Table 27 Global Antithrombotic Drugs Market Outlook, By Thromboembolic disease treatment (2014-2022) ($MN)
Table 28 Global Antithrombotic Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 29 Global Antithrombotic Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 30 Global Antithrombotic Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 31 Global Antithrombotic Drugs Market Outlook, By Online Retailers (2014-2022) ($MN)
Table 32 Global Antithrombotic Drugs Market Outlook, By General Pharmacies (2014-2022) ($MN)
Table 33 Global Antithrombotic Drugs Market Outlook, By Drug Stores (2014-2022) ($MN)
Table 34 North America Antithrombotic Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 35 North America Antithrombotic Drugs Market Outlook, By Drug Type (2014-2022) ($MN)
Table 36 North America Antithrombotic Drugs Market Outlook, By Anticoagulant (2014-2022) ($MN)
Table 37 North America Antithrombotic Drugs Market Outlook, By Thrombolytic drugs (2014-2022) ($MN)
Table 38 North America Antithrombotic Drugs Market Outlook, By Antiplatelet (2014-2022) ($MN)
Table 39 North America Antithrombotic Drugs Market Outlook, By Drug Class (2014-2022) ($MN)
Table 40 North America Antithrombotic Drugs Market Outlook, By Edoxaban (2014-2022) ($MN)
Table 41 North America Antithrombotic Drugs Market Outlook, By Fondaparinux (2014-2022) ($MN)
Table 42 North America Antithrombotic Drugs Market Outlook, By Heparin (2014-2022) ($MN)
Table 43 North America Antithrombotic Drugs Market Outlook, By Apixaban (2014-2022) ($MN)
Table 44 North America Antithrombotic Drugs Market Outlook, By Debigatran (2014-2022) ($MN)
Table 45 North America Antithrombotic Drugs Market Outlook, By Rivaroxaban (2014-2022) ($MN)
Table 46 North America Antithrombotic Drugs Market Outlook, By Indication (2014-2022) ($MN)
Table 47 North America Antithrombotic Drugs Market Outlook, By Myocardial infarction (MI) (2014-2022) ($MN)
Table 48 North America Antithrombotic Drugs Market Outlook, By Venous thromboembolism (VTE) (2014-2022) ($MN)
Table 49 North America Antithrombotic Drugs Market Outlook, By Stroke (2014-2022) ($MN)
Table 50 North America Antithrombotic Drugs Market Outlook, By Acute coronary syndrome (ACS) (2014-2022) ($MN)
Table 51 North America Antithrombotic Drugs Market Outlook, By Peripheral arterial occlusion (PAO) (2014-2022) ($MN)
Table 52 North America Antithrombotic Drugs Market Outlook, By Other Indications (2014-2022) ($MN)
Table 53 North America Antithrombotic Drugs Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 54 North America Antithrombotic Drugs Market Outlook, By Oral route (2014-2022) ($MN)
Table 55 North America Antithrombotic Drugs Market Outlook, By Parenteral route (2014-2022) ($MN)
Table 56 North America Antithrombotic Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 57 North America Antithrombotic Drugs Market Outlook, By Blood clot prevention (2014-2022) ($MN)
Table 58 North America Antithrombotic Drugs Market Outlook, By Hyperlipidemia treatment (2014-2022) ($MN)
Table 59 North America Antithrombotic Drugs Market Outlook, By Prophylactic treatment (2014-2022) ($MN)
Table 60 North America Antithrombotic Drugs Market Outlook, By Thromboembolic disease treatment (2014-2022) ($MN)
Table 61 North America Antithrombotic Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 62 North America Antithrombotic Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 63 North America Antithrombotic Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 64 North America Antithrombotic Drugs Market Outlook, By Online Retailers (2014-2022) ($MN)
Table 65 North America Antithrombotic Drugs Market Outlook, By General Pharmacies (2014-2022) ($MN)
Table 66 North America Antithrombotic Drugs Market Outlook, By Drug Stores (2014-2022) ($MN)
Table 67 Europe Antithrombotic Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 68 Europe Antithrombotic Drugs Market Outlook, By Drug Type (2014-2022) ($MN)
Table 69 Europe Antithrombotic Drugs Market Outlook, By Anticoagulant (2014-2022) ($MN)
Table 70 Europe Antithrombotic Drugs Market Outlook, By Thrombolytic drugs (2014-2022) ($MN)
Table 71 Europe Antithrombotic Drugs Market Outlook, By Antiplatelet (2014-2022) ($MN)
Table 72 Europe Antithrombotic Drugs Market Outlook, By Drug Class (2014-2022) ($MN)
Table 73 Europe Antithrombotic Drugs Market Outlook, By Edoxaban (2014-2022) ($MN)
Table 74 Europe Antithrombotic Drugs Market Outlook, By Fondaparinux (2014-2022) ($MN)
Table 75 Europe Antithrombotic Drugs Market Outlook, By Heparin (2014-2022) ($MN)
Table 76 Europe Antithrombotic Drugs Market Outlook, By Apixaban (2014-2022) ($MN)
Table 77 Europe Antithrombotic Drugs Market Outlook, By Debigatran (2014-2022) ($MN)
Table 78 Europe Antithrombotic Drugs Market Outlook, By Rivaroxaban (2014-2022) ($MN)
Table 79 Europe Antithrombotic Drugs Market Outlook, By Indication (2014-2022) ($MN)
Table 80 Europe Antithrombotic Drugs Market Outlook, By Myocardial infarction (MI) (2014-2022) ($MN)
Table 81 Europe Antithrombotic Drugs Market Outlook, By Venous thromboembolism (VTE) (2014-2022) ($MN)
Table 82 Europe Antithrombotic Drugs Market Outlook, By Stroke (2014-2022) ($MN)
Table 83 Europe Antithrombotic Drugs Market Outlook, By Acute coronary syndrome (ACS) (2014-2022) ($MN)
Table 84 Europe Antithrombotic Drugs Market Outlook, By Peripheral arterial occlusion (PAO) (2014-2022) ($MN)
Table 85 Europe Antithrombotic Drugs Market Outlook, By Other Indications (2014-2022) ($MN)
Table 86 Europe Antithrombotic Drugs Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 87 Europe Antithrombotic Drugs Market Outlook, By Oral route (2014-2022) ($MN)
Table 88 Europe Antithrombotic Drugs Market Outlook, By Parenteral route (2014-2022) ($MN)
Table 89 Europe Antithrombotic Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 90 Europe Antithrombotic Drugs Market Outlook, By Blood clot prevention (2014-2022) ($MN)
Table 91 Europe Antithrombotic Drugs Market Outlook, By Hyperlipidemia treatment (2014-2022) ($MN)
Table 92 Europe Antithrombotic Drugs Market Outlook, By Prophylactic treatment (2014-2022) ($MN)
Table 93 Europe Antithrombotic Drugs Market Outlook, By Thromboembolic disease treatment (2014-2022) ($MN)
Table 94 Europe Antithrombotic Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 95 Europe Antithrombotic Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 96 Europe Antithrombotic Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 97 Europe Antithrombotic Drugs Market Outlook, By Online Retailers (2014-2022) ($MN)
Table 98 Europe Antithrombotic Drugs Market Outlook, By General Pharmacies (2014-2022) ($MN)
Table 99 Europe Antithrombotic Drugs Market Outlook, By Drug Stores (2014-2022) ($MN)
Table 100 Asia Pacific Antithrombotic Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 101 Asia Pacific Antithrombotic Drugs Market Outlook, By Drug Type (2014-2022) ($MN)
Table 102 Asia Pacific Antithrombotic Drugs Market Outlook, By Anticoagulant (2014-2022) ($MN)
Table 103 Asia Pacific Antithrombotic Drugs Market Outlook, By Thrombolytic drugs (2014-2022) ($MN)
Table 104 Asia Pacific Antithrombotic Drugs Market Outlook, By Antiplatelet (2014-2022) ($MN)
Table 105 Asia Pacific Antithrombotic Drugs Market Outlook, By Drug Class (2014-2022) ($MN)
Table 106 Asia Pacific Antithrombotic Drugs Market Outlook, By Edoxaban (2014-2022) ($MN)
Table 107 Asia Pacific Antithrombotic Drugs Market Outlook, By Fondaparinux (2014-2022) ($MN)
Table 108 Asia Pacific Antithrombotic Drugs Market Outlook, By Heparin (2014-2022) ($MN)
Table 109 Asia Pacific Antithrombotic Drugs Market Outlook, By Apixaban (2014-2022) ($MN)
Table 110 Asia Pacific Antithrombotic Drugs Market Outlook, By Debigatran (2014-2022) ($MN)
Table 111 Asia Pacific Antithrombotic Drugs Market Outlook, By Rivaroxaban (2014-2022) ($MN)
Table 112 Asia Pacific Antithrombotic Drugs Market Outlook, By Indication (2014-2022) ($MN)
Table 113 Asia Pacific Antithrombotic Drugs Market Outlook, By Myocardial infarction (MI) (2014-2022) ($MN)
Table 114 Asia Pacific Antithrombotic Drugs Market Outlook, By Venous thromboembolism (VTE) (2014-2022) ($MN)
Table 115 Asia Pacific Antithrombotic Drugs Market Outlook, By Stroke (2014-2022) ($MN)
Table 116 Asia Pacific Antithrombotic Drugs Market Outlook, By Acute coronary syndrome (ACS) (2014-2022) ($MN)
Table 117 Asia Pacific Antithrombotic Drugs Market Outlook, By Peripheral arterial occlusion (PAO) (2014-2022) ($MN)
Table 118 Asia Pacific Antithrombotic Drugs Market Outlook, By Other Indications (2014-2022) ($MN)
Table 119 Asia Pacific Antithrombotic Drugs Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 120 Asia Pacific Antithrombotic Drugs Market Outlook, By Oral route (2014-2022) ($MN)
Table 121 Asia Pacific Antithrombotic Drugs Market Outlook, By Parenteral route (2014-2022) ($MN)
Table 122 Asia Pacific Antithrombotic Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 123 Asia Pacific Antithrombotic Drugs Market Outlook, By Blood clot prevention (2014-2022) ($MN)
Table 124 Asia Pacific Antithrombotic Drugs Market Outlook, By Hyperlipidemia treatment (2014-2022) ($MN)
Table 125 Asia Pacific Antithrombotic Drugs Market Outlook, By Prophylactic treatment (2014-2022) ($MN)
Table 126 Asia Pacific Antithrombotic Drugs Market Outlook, By Thromboembolic disease treatment (2014-2022) ($MN)
Table 127 Asia Pacific Antithrombotic Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 128 Asia Pacific Antithrombotic Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 129 Asia Pacific Antithrombotic Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 130 Asia Pacific Antithrombotic Drugs Market Outlook, By Online Retailers (2014-2022) ($MN)
Table 131 Asia Pacific Antithrombotic Drugs Market Outlook, By General Pharmacies (2014-2022) ($MN)
Table 132 Asia Pacific Antithrombotic Drugs Market Outlook, By Drug Stores (2014-2022) ($MN)
Table 133 RoW Antithrombotic Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 134 RoW Antithrombotic Drugs Market Outlook, By Drug Type (2014-2022) ($MN)
Table 135 RoW Antithrombotic Drugs Market Outlook, By Anticoagulant (2014-2022) ($MN)
Table 136 RoW Antithrombotic Drugs Market Outlook, By Thrombolytic drugs (2014-2022) ($MN)
Table 137 RoW Antithrombotic Drugs Market Outlook, By Antiplatelet (2014-2022) ($MN)
Table 138 RoW Antithrombotic Drugs Market Outlook, By Drug Class (2014-2022) ($MN)
Table 139 RoW Antithrombotic Drugs Market Outlook, By Edoxaban (2014-2022) ($MN)
Table 140 RoW Antithrombotic Drugs Market Outlook, By Fondaparinux (2014-2022) ($MN)
Table 141 RoW Antithrombotic Drugs Market Outlook, By Heparin (2014-2022) ($MN)
Table 142 RoW Antithrombotic Drugs Market Outlook, By Apixaban (2014-2022) ($MN)
Table 143 RoW Antithrombotic Drugs Market Outlook, By Debigatran (2014-2022) ($MN)
Table 144 RoW Antithrombotic Drugs Market Outlook, By Rivaroxaban (2014-2022) ($MN)
Table 145 RoW Antithrombotic Drugs Market Outlook, By Indication (2014-2022) ($MN)
Table 146 RoW Antithrombotic Drugs Market Outlook, By Myocardial infarction (MI) (2014-2022) ($MN)
Table 147 RoW Antithrombotic Drugs Market Outlook, By Venous thromboembolism (VTE) (2014-2022) ($MN)
Table 148 RoW Antithrombotic Drugs Market Outlook, By Stroke (2014-2022) ($MN)
Table 149 RoW Antithrombotic Drugs Market Outlook, By Acute coronary syndrome (ACS) (2014-2022) ($MN)
Table 150 RoW Antithrombotic Drugs Market Outlook, By Peripheral arterial occlusion (PAO) (2014-2022) ($MN)
Table 151 RoW Antithrombotic Drugs Market Outlook, By Other Indications (2014-2022) ($MN)
Table 152 RoW Antithrombotic Drugs Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 153 RoW Antithrombotic Drugs Market Outlook, By Oral route (2014-2022) ($MN)
Table 154 RoW Antithrombotic Drugs Market Outlook, By Parenteral route (2014-2022) ($MN)
Table 155 RoW Antithrombotic Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 156 RoW Antithrombotic Drugs Market Outlook, By Blood clot prevention (2014-2022) ($MN)
Table 157 RoW Antithrombotic Drugs Market Outlook, By Hyperlipidemia treatment (2014-2022) ($MN)
Table 158 RoW Antithrombotic Drugs Market Outlook, By Prophylactic treatment (2014-2022) ($MN)
Table 159 RoW Antithrombotic Drugs Market Outlook, By Thromboembolic disease treatment (2014-2022) ($MN)
Table 160 RoW Antithrombotic Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 161 RoW Antithrombotic Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 162 RoW Antithrombotic Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 163 RoW Antithrombotic Drugs Market Outlook, By Online Retailers (2014-2022) ($MN)
Table 164 RoW Antithrombotic Drugs Market Outlook, By General Pharmacies (2014-2022) ($MN)
Table 165 RoW Antithrombotic Drugs Market Outlook, By Drug Stores (2014-2022) ($MN)